Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalibu Life Regulatory News (MLHL)

Share Price Information for Malibu Life (MLHL)

Share Price is delayed by 15 minutes
Get Live Data
15.80    -0.05 (-0.31%)
Bid:
15.80
Ask:
15.90
Spread: 0.10 (0.633%)
Market Cap: $269.72m
MLHL Live PriceLast checked at - London Stock Exchange

Intraday Malibu Life Share Chart

PDMR / PCA Announcement

18 Sep 2025 15:40

Third Point Investors Ltd - PDMR / PCA Announcement

Third Point Investors Ltd - PDMR / PCA Announcement

PR Newswire

LONDON, United Kingdom, September 18

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE.

 

18 September 2025

Third Point Investors Limited

PDMR / PCA Announcement

 

Background

 

On 23 July 2025, Third Point Investors Limited (the "Company") entered into subscription agreements with: (i) Mr Joshua Targoff, whose appointment as a non-executive director of the Company was effective on 12 September 2025, for Mr Targoff to subscribe for up to $1,000,000 worth of the Company's ordinary shares (the "Ordinary Shares"); (ii) Mr Dimitri Goulandris, a non-executive director and Chair of the Company, for Mr Goulandris to subscribe for up to $500,000 worth of Ordinary Shares; and (iii) Gatemore Special Opportunities Master Fund Ltd, an investment company controlled by Mr Liad Meidar, a non-executive director of the Company, to subscribe for up to $2,500,000 worth of Ordinary Shares (together, the "Subscription Agreements").

 

Under each Subscription Agreement, the price per Ordinary Share to be paid (the "Subscription Price") is determined by reference to the Company's NAV on the final day of the month in which the relevant conditions to the Company's acquisition of Malibu Life Reinsurance SPC under the Sale and Purchase Agreement (the "Acquisition") were satisfied. Settlement under the Subscription Agreements occurs on or around the date of the completion of the Acquisition ("Completion").

 

The Company announced on 4 September 2025 that the necessary conditions to the Acquisition had been satisfied and the Subscription Price was $28.56 based on the Company's NAV calculated as of 31 August 2025. Completion and settlement under the Subscription Agreements occurred on 12 September 2025.

 

PDMR / PCA Announcement

 

In accordance with Article 19 UK MAR, the Company has received the following notifications regarding the acquisition of Ordinary Shares:

 

1.

Details of PDMR / PCA

a)

Name of PDMR

Joshua Targoff

b)

Position / status

Joshua Targoff - Non-Executive Director

c)

Name of PCA

N/A

d)

Relationship to PDMR

N/A

2.

Initial notification / amendment

Initial Notification

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares 

ISIN: KYG8827C1006

b)

Nature of the transaction

Off market subscription/purchase of ordinary shares pursuant to a subscription agreement dated 23 July 2025.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD 28.56 per share

35,014

 

 

d)

Aggregated information

 

Aggregated volume Price

35,014

 

 

USD 999,999.84

e)

Date of the transaction

12/09/2025

f)

Place of the transaction

London Stock Exchange

g)

Currency

USD - Dollars

 

1.

Details of PDMR / PCA

a)

Name of PDMR

Dimitri Goulandris

b)

Position / status

Dimitri Goulandris - Non-Executive Director

c)

Name of PCA

N/A

d)

Relationship to PDMR

N/A

2.

Initial notification / amendment

Initial Notification

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares 

ISIN: KYG8827C1006

b)

Nature of the transaction

Off market subscription/purchase of ordinary shares pursuant to a subscription agreement dated 23 July 2025.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD 28.56 per share

17,507

 

 

d)

Aggregated information

 

Aggregated volume Price

17,507

 

 

USD 499,999.92

e)

Date of the transaction

12/09/2025

f)

Place of the transaction

London Stock Exchange

g)

Currency

USD - Dollars

 

1.

Details of PDMR / PCA

a)

Name of PDMR

Liad Meidar

b)

Position / status

Liad Meidar - Non-Executive Director

c)

Name of PCA

Gatemore Special Opportunities Master Fund Ltd

d)

Relationship to PDMR

Legal person controlled by Mr Meidar

2.

Initial notification / amendment

Initial Notification

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares 

ISIN: KYG8827C1006

b)

Nature of the transaction

Off market subscription/purchase of ordinary shares pursuant to a subscription agreement dated 23 July 2025.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

USD 28.56 per share

87,535

 

 

d)

Aggregated information

 

Aggregated volume Price

87,535

 

 

USD 2,499,999.60

e)

Date of the transaction

12/09/2025

f)

Place of the transaction

London Stock Exchange

g)

Currency

USD - Dollars

 

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's circular dated 25 July 2025.

 

Enquiries:

Walkers Corporate Limited (Company secretary to the Company)

 

Michael Beck 

+1 (345) 814-7600

 



Date   Source Headline
4th Jun 20267:00 amPRNThird Point Master Fund May 2026 Performance
14th May 20267:00 amPRNMalibu Life Appoints Todd D. Shriber as CEO
6th May 20267:00 amPRNThird Point Master Fund April 2026 Performance
22nd Apr 20263:30 pmPRN2025 Results Webcast Replay
22nd Apr 20267:00 amPRNFinal Results for the Year Ended 31 December 2025
7th Apr 20267:00 amPRNThird Point Master Fund[1] Monthly Update: March 2026 Performance
25th Mar 20267:00 amPRNNotice of Annual Report Release and Virtual Results Presentation
5th Mar 20267:00 amPRNThird Point Master Fund February 2026 Performance
3rd Mar 20267:00 amPRNMalibu Life Announces Hiring of COO
5th Feb 20262:44 pmPRNReplacement : Third Point Master Fund Monthly Update: January 2026 Performance
5th Feb 20267:00 amPRNThird Point Master Fund1 Monthly Update: December 2025 Performance
28th Jan 20267:00 amPRNFinal number of Consideration Shares and Update on total voting rights
21st Jan 20263:03 pmPRNPDMR Announcement
15th Jan 20261:22 pmPRNPDMR Announcement
7th Jan 20267:00 amPRNThird Point Master Fund December 2025 Performance
4th Dec 20257:00 amPRNThird Point Master Fund November 2025 Performance
6th Nov 20252:01 pmPRNPDMR Announcement
6th Nov 20257:00 amPRNThird Point Master Fund October 2025 Performance
23rd Oct 20253:59 pmPRNHolding(s) in Company
23rd Oct 20253:58 pmPRNHolding(s) in Company
20th Oct 20257:00 amPRNPDMR/PCA Announcement
14th Oct 20257:00 amPRNMalibu Life Enters into Agreement to Acquire TruSpire
6th Oct 20254:20 pmPRNThird Point Master Fund September 2025 Performance
1st Oct 20253:44 pmPRNMonthly Final Net Asset Value - August 2025
30th Sep 20257:00 amPRNHalf-year Report
25th Sep 20255:25 pmPRNHolding(s) in Company
25th Sep 20255:22 pmPRNCorrection : Holding(s) in Company
24th Sep 202512:09 pmPRNTotal voting rights: correction
24th Sep 20257:00 amPRNChange of Name Becoming Effective
19th Sep 202511:34 amPRNPayment of the Initial Redemption Consideration per Ordinary Share & Total voting rights following the Redemption Date
18th Sep 20255:39 pmPRNHolding(s) in Company
18th Sep 20253:40 pmPRNPDMR / PCA Announcement
12th Sep 20257:00 amPRNCompletion of the Acquisition, Admission to the Main Market for listed securities of the London Stock Exchange
11th Sep 20258:13 amPRNCompletion of Migration Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.